Optimer Says Diarrhea Drug Successful in Second Trial

Optimer Pharmaceuticals Inc said the second late-stage study for Prulifloxacin to treat infectious diarrhea met the main goal and plans to file for regulatory approval by the end of 2009.
CNBC